Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics

  title={Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics},
  author={Acmg PoliCy StAteMent},
  journal={Genetics in Medicine},
Disclaimer: These recommendations are designed primarily as an educational resource for medical geneticists and other health-care providers to help them provide quality medical genetics services. Adherence to these recommendations does not necessarily ensure a successful medical outcome. These recommendations should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. In determining… Expand

Paper Mentions

Interventional Clinical Trial
The "North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing, 2 (NCGENES 2)" study is part of a larger consortium project investigating the clinical utility, or net… Expand
ConditionsAutism Spectrum Disorder, Brain Malformation, Chromosome Abnormality, (+14 more)
InterventionBehavioral, Diagnostic Test
The utility of genetic testing in neuromuscular disease: A consensus statement from the AANEM on the clinical utility of genetic testing in diagnosis of neuromuscular disease
The AANEM believes that performing genetic testing to arrive at a specific molecular diagnosis is a critical step in providing high‐quality care to neuromuscular patients and the cost of testing should not be a deterrent. Expand
Current approaches to genetic testing in pediatric disease
This chapter provides an overview of the currently available clinical genetic and genomic testing, such as chromosomal microarray, conventional karyotype, FISH, single-gene sequencing, disease-targeted gene panels, whole-exome sequencing, whole the genome sequencing, and methylation analysis, among others, and describes their advantages and limitations. Expand
Laboratory Stewardship for Clinical Genetic Testing
A variety of stewardship interventions exist that collectively help to eliminate unnecessary tests, support coordination of necessary tests, reduce order errors, and integrate processes that ensure results retrieval and accurate interpretation. Expand
Cases in Precision Medicine: Should You Participate in a Study Involving Genomic Sequencing of Your Patients?
Decisions about participation in clinical research should be made thoughtfully, particularly because integration of genomic medicine into clinical care, including disclosure of genomic sequencing results to patients and research participants, is still a work in progress. Expand
Genetic testing costs and compliance with clinical best practices
The costs of genetic testing and compliance with published guidelines and clinical best practices at a tertiary teaching hospital in California were determined and a cost analysis was performed comparing the costs of ordered tests to the cost of the recommended testing. Expand
Physicians’ Attitudes and Ethical Obligations to Pharmacogenetic Testing
The findings showed that collecting both verbal and written consents was imperative prior to testing, and unless the field of PGt testing addresses the ethical challenges that might be encountered during PGt treatment, these issues might influence its acceptance in routine clinical settings. Expand
Clinical utility of genomic sequencing: a measurement toolkit
This work aligns with a broad definition of clinical utility and proposes a conceptually-grounded and empirically-guided measurement toolkit focused on four domains of utility: diagnostic thinking efficacy, therapeutic efficacy, patient outcome efficacy, and societal efficacy. Expand
Genomic medicine for kidney disease
Pilot studies suggest that genetic testing can also provide similar diagnostic insight among adult patients, and the creation of evidence-based guidelines for the utilization and implementation of genetic testing in nephrology will help to translate genetic knowledge into improved clinical outcomes for patients with kidney disease. Expand
Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics.
Though there was a high PAR approval rate, the findings suggest that insurance coverage remains one barrier to genetic testing. Expand
Clinical implementation of an oncology‐specific family health history risk assessment tool
Using a patient-facing risk assessment platform enhances the ability to identify patients systematically and with widespread acceptability and recognized value by patients to optimize hereditary risk assessment in oncology practices. Expand


What is the clinical utility of genetic testing?
The evolution of the concept of clinical utility of biochemical or molecular testing for genotypic variations associated with risk of disease is reviewed, with a conclusion that multiple perspectives should be considered in the evaluation of genetic testing. Expand
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
It is recommended that laboratories performing clinical sequencing seek and report mutations of the specified classes or types in the genes listed here and encourage the creation of an ongoing process for updating these recommendations at least annually as further data are collected. Expand
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
  • M. Robson, A. Bradbury, +7 authors N. Lindor
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2015
This statement makes recommendations in the following areas: germline implications of somatic mutation profiling, multigene panel testing for cancer susceptibility, quality assurance in genetic testing, education of oncology professionals, and access to cancer genetic services. Expand
Promoting safe and effective genetic testing in the United States: Final Report of the Task Force on Genetic Testing.
Reading promoting safe and effective genetic testing in the united states fi is also a way as one of the collective books that gives many advantages. Expand
Ending a diagnostic odyssey
  • blog/16008/. Accessed
  • 2015